COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 163 filers reported holding COHERUS BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,587 | -6.0% | 19,141 | +7.3% | 0.00% | – |
| Q2 2023 | $76,185 | -29.6% | 17,842 | +12.8% | 0.00% | – |
| Q1 2023 | $108,222 | -23.2% | 15,822 | -11.1% | 0.00% | – |
| Q4 2022 | $140,921 | -10.8% | 17,793 | +8.4% | 0.00% | -100.0% |
| Q3 2022 | $158,000 | +35.0% | 16,412 | +1.6% | 0.00% | – |
| Q2 2022 | $117,000 | -59.5% | 16,148 | -27.9% | 0.00% | -100.0% |
| Q1 2022 | $289,000 | -33.1% | 22,408 | -17.0% | 0.00% | 0.0% |
| Q4 2021 | $432,000 | +2.6% | 27,010 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $421,000 | -5.2% | 26,191 | -18.3% | 0.00% | 0.0% |
| Q2 2021 | $444,000 | +9.9% | 32,070 | +15.9% | 0.00% | 0.0% |
| Q1 2021 | $404,000 | -8.4% | 27,680 | +9.1% | 0.00% | -50.0% |
| Q4 2020 | $441,000 | +21.8% | 25,369 | +28.4% | 0.00% | 0.0% |
| Q3 2020 | $362,000 | +0.3% | 19,753 | -2.3% | 0.00% | 0.0% |
| Q2 2020 | $361,000 | +67.1% | 20,221 | +51.9% | 0.00% | 0.0% |
| Q1 2020 | $216,000 | -49.3% | 13,310 | -43.7% | 0.00% | 0.0% |
| Q4 2019 | $426,000 | -18.9% | 23,649 | -8.8% | 0.00% | -33.3% |
| Q3 2019 | $525,000 | -7.7% | 25,935 | +0.7% | 0.00% | 0.0% |
| Q2 2019 | $569,000 | +43.0% | 25,745 | -11.7% | 0.00% | +50.0% |
| Q1 2019 | $398,000 | +54.3% | 29,171 | +2.3% | 0.00% | 0.0% |
| Q4 2018 | $258,000 | -54.0% | 28,525 | -16.1% | 0.00% | -50.0% |
| Q3 2018 | $561,000 | +16.6% | 34,006 | -1.1% | 0.00% | +33.3% |
| Q2 2018 | $481,000 | +32.9% | 34,369 | +5.0% | 0.00% | +50.0% |
| Q1 2018 | $362,000 | +11.4% | 32,730 | -11.3% | 0.00% | 0.0% |
| Q4 2017 | $325,000 | -31.0% | 36,914 | +4.7% | 0.00% | -50.0% |
| Q3 2017 | $471,000 | +10.6% | 35,255 | +18.6% | 0.00% | 0.0% |
| Q2 2017 | $426,000 | -35.4% | 29,715 | -4.7% | 0.00% | -42.9% |
| Q1 2017 | $659,000 | -30.3% | 31,180 | -7.1% | 0.01% | -30.0% |
| Q4 2016 | $945,000 | +14.4% | 33,575 | +8.8% | 0.01% | -16.7% |
| Q3 2016 | $826,000 | +49.4% | 30,860 | -5.7% | 0.01% | +71.4% |
| Q2 2016 | $553,000 | -18.2% | 32,741 | +2.9% | 0.01% | -22.2% |
| Q1 2016 | $676,000 | -15.2% | 31,829 | -8.3% | 0.01% | -10.0% |
| Q4 2015 | $797,000 | – | 34,708 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,868,221 | $39,123,000 | 3.77% |
| Rubric Capital Management LP | 2,640,771 | $36,020,000 | 3.36% |
| Ghost Tree Capital, LLC | 450,000 | $6,138,000 | 1.60% |
| Hound Partners | 1,959,318 | $26,725,000 | 1.15% |
| Sivik Global Healthcare LLC | 225,000 | $3,069,000 | 1.13% |
| Pier Capital, LLC | 525,848 | $7,173,000 | 1.11% |
| Rhenman & Partners Asset Management AB | 451,131 | $6,153,000 | 0.72% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,055,055 | $41,671,000 | 0.63% |
| Temasek Holdings (Private) Ltd | 6,556,116 | $89,425,000 | 0.62% |
| Atika Capital Management LLC | 188,000 | $2,564,000 | 0.52% |